Researchers at the Tulane National Primate Research Center co-authored a study that shows a new COVID-19 vaccine offers protection against Omicron variants of SARS-CoV-2 for at least six months. The trial tested a vaccine, which is currently in use in South Korea, on nonhuman primates.
Link
https://tulane.it/omicron-vaccine
Issue
Horizontal thumbnail
